Choline

Choline

SCHEMBL15527809

CS(=O)(=O)[O-].C[N+](C)(C)CCO

nearest known ligand 0.63

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADORA1ADORA2AADORA2BADORA3GNRHRMPLPDE3APDE3BPDE4APDE4BPDE4CPDE4DPPARASLC5A2

The experimentally established mechanism targets of Choline. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.60
KMT2A Q03164 3/20 0.60
LMNA P02545 2/20 0.60
CYP3A4 P08684 1/20 0.60
SLC5A7 Q9GZV3 1/20 0.60
BBOX1 O75936 3/20 0.46
SLC6A4 P31645 1/20 0.41
APAF1 O14727 1/20 0.36
POLB P06746 1/20 0.36
GRK2 P25098 1/20 0.36
DNMT1 P26358 1/20 0.36
PTPN7 P35236 1/20 0.36
RECQL P46063 1/20 0.36
BLM P54132 1/20 0.36
PPP1CA P62136 1/20 0.36
CTDSP1 Q9GZU7 1/20 0.36
PTPN22 Q9Y2R2 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
GALR3 O60755 1/20 0.35
ACHE P22303 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Choline SCHEMBL339062 0.92 MEN1 (0.63) MEN1KMT2ALMNACYP3A4SLC5A7
Choline SCHEMBL2351951 0.92 MEN1 (0.63) MEN1KMT2ALMNACYP3A4SLC5A7
Choline SCHEMBL339064 0.90 MEN1 (0.60) MEN1KMT2ALMNACYP3A4SLC5A7
Choline SCHEMBL3790708 0.90 MEN1 (0.60) MEN1KMT2ALMNACYP3A4SLC5A7
Choline SCHEMBL3790705 0.90 MEN1 (0.60) MEN1KMT2ALMNACYP3A4SLC5A7
Choline SCHEMBL872578 0.90 MEN1 (0.60) MEN1KMT2ALMNACYP3A4SLC5A7
Choline SCHEMBL3790706 0.90 MEN1 (0.60) MEN1KMT2ALMNACYP3A4SLC5A7
Choline SCHEMBL3791421 0.90 MEN1 (0.60) MEN1KMT2ALMNACYP3A4SLC5A7
Choline SCHEMBL872580 0.90 MEN1 (0.60) MEN1KMT2ALMNACYP3A4SLC5A7
Choline SCHEMBL31591121 0.89 MEN1 (0.67) MEN1KMT2ALMNACYP3A4SLC5A7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260015560-A1 COMPOSITIONS FOR POST-CMP CLEANING OF MICROELECTRONIC DEVICES ENTEGRIS INC (US) 2026-01-15 US claimed
CN-117069901-A Lignin-based phenolic resin and preparation method thereof 江苏理文造纸有限公司 2023-11-17 CN claimed
EP-3244987-B1 SEPARATIONS WITH IONIC LIQUID SOLVENTS CHEVRON PHILLIPS CHEMICAL CO LP (US) 2022-06-22 EP claimed
US-10227274-B2 Separations with ionic liquid solvents CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2019-03-12 US claimed
EP-3244987-A1 SEPARATIONS WITH IONIC LIQUID SOLVENTS Chevron Phillips Chemical Company LP (US) 2017-11-22 EP claimed
US-9238611-B2 Process for separating aryl carboxylic acids RELIANCE INDUSTRIES LIMITED (IN) 2016-01-19 US claimed
WO-2015166507-A1 A PROCESS FOR PRODUCING AROMATIC DICARBOXYLIC ACIDS RELIANCE INDUSTRIES LIMITED (IN) 2015-11-05 WO claimed
US-20150133711-A1 Separations With Ionic Liquid Solvents CHEVRON PHILLIPS CHEMICAL COMPANY LP 2015-05-14 US claimed
US-20150065748-A1 PROCESS FOR SEPARATING ARYL CARBOXYLIC ACIDS RELIANCE INDUSTRIES LIMITED (IN) 2015-03-05 US claimed
EP-2831027-A1 A PROCESS FOR SEPARATING ARYL CARBOXYLIC ACIDS Reliance Industries Limited (IN) 2015-02-04 EP claimed
WO-2013164852-A1 A PROCESS FOR SEPARATING ARYL CARBOXYLIC ACIDS RELIANCE INDUSTRIES LIMITED (IN) 2013-11-07 WO claimed
EP-4493623-B1 PET DEPOLYMERIZATION PROCESS REPET S R L (IT) 2026-01-21 EP disclosed
US-20260015560-A1 COMPOSITIONS FOR POST-CMP CLEANING OF MICROELECTRONIC DEVICES ENTEGRIS INC (US) 2026-01-15 US disclosed
US-20250090437-A1 COSMETIC COMPOUNDING AGENT, COSMETIC AND PRODUCTION METHOD THEREOF MIYOSHI YUSHI KK (JP) 2025-03-20 US disclosed
EP-3345965-B1 ANTI-STATIC BICOMPONENT FORMULATION FOR UNSATURATED POLYESTER RESINS AND EPOXY VINYL ESTER RESINS AVANZARE INNOVACION TECNOLOGICA S L (ES) 2025-01-01 EP disclosed
CN-104805135-A Whole-cell catalytic synthesis method of vanilline UNIV SHENZHEN 2015-07-29 CN disclosed
US-20150133711-A1 Separations With Ionic Liquid Solvents CHEVRON PHILLIPS CHEMICAL COMPANY LP 2015-05-14 US disclosed
US-20150065748-A1 PROCESS FOR SEPARATING ARYL CARBOXYLIC ACIDS RELIANCE INDUSTRIES LIMITED (IN) 2015-03-05 US disclosed
EP-2831027-A1 A PROCESS FOR SEPARATING ARYL CARBOXYLIC ACIDS Reliance Industries Limited (IN) 2015-02-04 EP disclosed
WO-2013164852-A1 A PROCESS FOR SEPARATING ARYL CARBOXYLIC ACIDS RELIANCE INDUSTRIES LIMITED (IN) 2013-11-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260015560-A1 COMPOSITIONS FOR POST-CMP CLEANING OF MICROELECTRONIC DEVICES TET2, ASIC1, PIEZO1 MEN1 2976/4885KMT2A 778/4885LMNA 2078/4885
US-20250090437-A1 COSMETIC COMPOUNDING AGENT, COSMETIC AND PRODUCTION METHOD THEREOF CUTA, HAT1, NACA MEN1 643/4885KMT2A 961/4885LMNA 3747/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.